Literature DB >> 2045618

Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits.

R S Zeiger1, S Heller, M H Mellon, J Wald, R Falkoff, M Schatz.   

Abstract

Facilitated asthma-specialist care delivered by allergists was compared to generalist care on the rate of relapse of asthma emergency room (ER) visits and hospitalizations and on asthma control in a prospective, controlled study of San Diego Kaiser Health Plan members with asthma. Subjects with asthma between the ages of 6 and 59 years presenting for acute ER care for asthma were systematically assigned by alternating, consecutively, the day of their ER visit to receive either (1) facilitated referral to an asthma specialist within the allergy department and concomitant comprehensive ongoing asthma care (intervention group, n = 149) or (2) continued outpatient management from generalist physicians (control group, n = 160). The course of their asthma was evaluated blindly during the subsequent 6 months by review of medical records, initial and follow-up questionnaires, and spirometry. Compared to the control group, the intervention group noted (1) a 75% reduction in the number of, and percent of, subjects with asthma awakenings per night (p less than or equal to 0.0001), (2) an almost 50% reduction in asthma ER relapses (p = 0.017) resulting from a reduction in the frequency of multiple relapse (p = 0.005), and (3) a greater use of inhaled corticosteroids (p less than 0.00001) and cromolyn (p = 0.002). Thus, facilitated referral of subjects with asthma to specialists in asthma therapy after acute ER therapy appears to reduce asthma ER relapses and to improve asthma outcome.

Entities:  

Mesh:

Year:  1991        PMID: 2045618     DOI: 10.1016/0091-6749(91)92162-t

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  39 in total

Review 1.  Knowledge, patterns of care, and outcomes of care for generalists and specialists.

Authors:  L R Harrold; T S Field; J H Gurwitz
Journal:  J Gen Intern Med       Date:  1999-08       Impact factor: 5.128

2.  The next generation of research in provider optimization.

Authors:  S Greenfield
Journal:  J Gen Intern Med       Date:  1999-08       Impact factor: 5.128

Review 3.  Acute asthma.

Authors:  M FitzGerald
Journal:  BMJ       Date:  2001-10-13

Review 4.  Written action plans for asthma: an evidence-based review of the key components.

Authors:  P G Gibson; H Powell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

5.  Practice Variation in Management of Childhood Asthma Is Associated with Outcome Differences.

Authors:  Jane M Garbutt; Yan Yan; Robert C Strunk
Journal:  J Allergy Clin Immunol Pract       Date:  2016-01-20

6.  The impact of allergy and pulmonary specialist care on emergency asthma utilization in a large managed care organization.

Authors:  Sara Erickson; Irina Tolstykh; Joe V Selby; Guillermo Mendoza; Carlos Iribarren; Mark D Eisner
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

Review 7.  Asthma exacerbations . 4: Prevention.

Authors:  J M FitzGerald; P G Gibson
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 8.  Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.

Authors:  J P Guevara; F M Ducharme; R Keren; S Nihtianova; J Zorc
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

9.  Action plans in patients presenting to emergency departments with asthma exacerbations: Frequency of use and description of contents.

Authors:  Elfriede Cross; Cristina Villa-Roel; Sumit R Majumdar; Mohit Bhutani; Rhonda J Rosychuk; Stephanie Couperthwaite; Brian H Rowe
Journal:  Can Respir J       Date:  2014 November/December       Impact factor: 2.409

10.  Asthma at the interface: bridging the gap between general practice and a district general hospital.

Authors:  I Charlton; A G Antoniou; J Atkinson; M J Campbell; E Chapman; T Mackintosh; D Schapira
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.